\-\ Texto\\:\\ \ \(0\)\
\-\ negative\\ sonographic\\ murphy\\'s\\.\ \(0\)\
\-\ normal\\ lft\\'s\\.\ \(0\)\
\-\ the\\ clinician\\ and\\ the\\ patient\\ will\\ discuss\\ the\\ options\\,\\ though\\ continued\\ monitoring\\ is\\ a\\ likely\\ plan\\ given\\ the\\ patient\\'s\\ age\\.\ \(0\)\
\-\ 6mm\\ x\\ 12mm\\ x\\ 11mm\\ hypoechoic\\ filling\\ defect\\ in\\ the\\ posterior\\ gallbladder\\ wall\\ with\\ a\\ broad\\ based\\ stalk\\ and\\ no\\ evidence\\ of\\ abnormal\\ shadowing\\.\\ \\ normally\\ distended\\ gallbladder\\ with\\ no\\ evidence\\ of\\ wall\\ thickening\\ or\\ pericholecystic\\ fluid\\.\ \(0\)\
\-\ gallbladder\\ polyp\\,\\ histological\\ diagnosis\\ unknown\ \(0\)\
\-\ cholesterol\\ polyp\\,\\ adherent\\ stone\\ or\\ sludge\\,\\ adenomyomatosis\\,\\ carcinoma\\,\\ metastasis\\ \\(melanoma\\,\\ gi\\,\\ breast\\)\\,\\ ectopic\\ mucosa\\,\\ benign\\ tumor\\ \\â\\€\\“\\ adenoma\\,\\ papilloma\\,\\ lipoma\ \(0\)\
\-\ 86\\ yo\\ woman\\ with\\ intermittent\\,\\ vague\\ epigastric\\ pain\\ and\\ normal\\ liver\\ function\\ on\\ laboratory\\ analysis\\.\ \(1\)\
\-\ given\\ the\\ size\\ of\\ the\\ polyp\\ and\\ the\\ patient\\'s\\ demographic\\,\\ malignancy\\ is\\ the\\ diagnosis\\ of\\ exclusion\\,\\ though\\ no\\ concerning\\ findings\\ \\(other\\ than\\ size\\)\\ were\\ noted\\ on\\ the\\ ultrasound\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ polyp\\:\\ 0\\.0917787680261334\ \(0\)\
\-\ gallbladder\\:\\ 0\\.07747147589913518\ \(0\)\
\-\ though\\:\\ 0\\.04985519698172178\ \(0\)\
\-\ \\'s\\:\\ 0\\.04739739920420239\ \(0\)\
\-\ 11mm\\:\\ 0\\.046724679640544706\ \(0\)\
\-\ 12mm\\:\\ 0\\.04236526341060794\ \(0\)\
\-\ demographic\\:\\ 0\\.04236526341060794\ \(0\)\
\-\ lft\\:\\ 0\\.03981516839105974\ \(0\)\
\-\ adenomyomatosis\\:\\ 0\\.03931175513525133\ \(0\)\
\-\ adherent\\:\\ 0\\.038005847180671175\ \(0\)\
\-\ given\\:\\ 0\\.03684797978007978\ \(0\)\
\-\ 86\\:\\ 0\\.03629557224052248\ \(0\)\
\-\ size\\:\\ 0\\.03603617448275184\ \(0\)\
\-\ discuss\\:\\ 0\\.03600299352583763\ \(0\)\
\-\ exclusion\\:\\ 0\\.03600299352583763\ \(0\)\
\-\ x\\:\\ 0\\.035459953903741855\ \(0\)\
\-\ stalk\\:\\ 0\\.03545575216112297\ \(0\)\
\-\ 6mm\\:\\ 0\\.035199010057222\ \(0\)\
\-\ sludge\\:\\ 0\\.035199010057222\ \(0\)\
\-\ clinician\\:\\ 0\\.034486251030133926\ \(0\)\
\-\ pericholecystic\\:\\ 0\\.03405233359939838\ \(0\)\
\-\ cholesterol\\:\\ 0\\.03405233359939838\ \(0\)\
\-\ murphy\\:\\ 0\\.03345289850628942\ \(0\)\
\-\ histological\\:\\ 0\\.03345289850628942\ \(0\)\
\-\ plan\\:\\ 0\\.03290565714157477\ \(0\)\
\-\ epigastric\\:\\ 0\\.031502238579850184\ \(0\)\
\-\ wall\\:\\ 0\\.031134076984135173\ \(0\)\
\-\ monitoring\\:\\ 0\\.029692917369461624\ \(0\)\
\-\ vague\\:\\ 0\\.02890572779113454\ \(0\)\
\-\ shadowing\\:\\ 0\\.02854624091163801\ \(0\)\
\-\ mucosa\\:\\ 0\\.028373920319259928\ \(0\)\
\-\ concerning\\:\\ 0\\.028206195494843822\ \(0\)\
\-\ evidence\\:\\ 0\\.02818166771530664\ \(0\)\
\-\ broad\\:\\ 0\\.02788359615907306\ \(0\)\
\-\ melanoma\\:\\ 0\\.02742874923089931\ \(0\)\
\-\ analysis\\:\\ 0\\.02735603965604978\ \(0\)\
\-\ papilloma\\:\\ 0\\.02700459023218527\ \(0\)\
\-\ stone\\:\\ 0\\.02673691970124945\ \(0\)\
\-\ normally\\:\\ 0\\.02648017759734847\ \(0\)\
\-\ options\\:\\ 0\\.026113706477071896\ \(0\)\
\-\ sonographic\\:\\ 0\\.026054651506318187\ \(0\)\
\-\ distended\\:\\ 0\\.025996145892089803\ \(0\)\
\-\ ectopic\\:\\ 0\\.025767418570260398\ \(0\)\
\-\ \\,\\:\\ 0\\.02553868542615919\ \(0\)\
\-\ lipoma\\:\\ 0\\.02512727583875133\ \(0\)\
\-\ diagnosis\\:\\ 0\\.02468200416076\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.024500235837348262\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.024186824681701243\ \(0\)\
\-\ gi\\:\\ 0\\.02414329988393663\ \(0\)\
\-\ continued\\:\\ 0\\.023142892999473186\ \(0\)\
\-\ intermittent\\:\\ 0\\.02306933300096255\ \(0\)\
\-\ function\\:\\ 0\\.022783406119976656\ \(0\)\
\-\ adenoma\\:\\ 0\\.022443360703182466\ \(0\)\
\-\ filling\\:\\ 0\\.021636729662153038\ \(0\)\
\-\ unknown\\:\\ 0\\.020974084909588093\ \(0\)\
\-\ malignancy\\:\\ 0\\.020767859608814568\ \(0\)\
\-\ based\\:\\ 0\\.020494907938785917\ \(0\)\
\-\ defect\\:\\ 0\\.020117907712578157\ \(0\)\
\-\ metastasis\\:\\ 0\\.020117907712578157\ \(0\)\
\-\ breast\\:\\ 0\\.01982740845176448\ \(0\)\
\-\ laboratory\\:\\ 0\\.0198056084015979\ \(0\)\
\-\ benign\\:\\ 0\\.018547486585114476\ \(0\)\
\-\ liver\\:\\ 0\\.018529695036683797\ \(0\)\
\-\ thickening\\:\\ 0\\.018217764589266362\ \(0\)\
\-\ normal\\:\\ 0\\.01685047112703272\ \(0\)\
\-\ will\\:\\ 0\\.016814346027541775\ \(0\)\
\-\ age\\:\\ 0\\.016357926575750355\ \(0\)\
\-\ no\\:\\ 0\\.01623479529629815\ \(0\)\
\-\ yo\\:\\ 0\\.016172022159136868\ \(0\)\
\-\ patient\\:\\ 0\\.01616211190408279\ \(0\)\
\-\ negative\\:\\ 0\\.016051070197326253\ \(0\)\
\-\ ultrasound\\:\\ 0\\.015944167201297505\ \(0\)\
\-\ abnormal\\:\\ 0\\.015327624152923972\ \(0\)\
\-\ fluid\\:\\ 0\\.015274459777382725\ \(0\)\
\-\ carcinoma\\:\\ 0\\.015232249496955137\ \(0\)\
\-\ likely\\:\\ 0\\.015159056389532431\ \(0\)\
\-\ than\\:\\ 0\\.014082068269926251\ \(0\)\
\-\ noted\\:\\ 0\\.01273849804058235\ \(0\)\
\-\ or\\:\\ 0\\.012597770427216447\ \(0\)\
\-\ tumor\\:\\ 0\\.01252976290321265\ \(0\)\
\-\ woman\\:\\ 0\\.012414483946471109\ \(0\)\
\-\ posterior\\:\\ 0\\.012387663828317288\ \(0\)\
\-\ other\\:\\ 0\\.012387663828317288\ \(0\)\
\-\ were\\:\\ 0\\.01220305872132026\ \(0\)\
\-\ findings\\:\\ 0\\.011439226011257608\ \(0\)\
\-\ on\\:\\ 0\\.009105547325351297\ \(0\)\
\-\ \\(\\:\\ 0\\.009086311021935353\ \(0\)\
\-\ \\)\\:\\ 0\\.008975316881928366\ \(0\)\
\-\ the\\:\\ 0\\.008694923566265774\ \(0\)\
\-\ is\\:\\ 0\\.007072839979682084\ \(0\)\
\-\ pain\\:\\ 0\\.006563573380696445\ \(0\)\
\-\ a\\:\\ 0\\.0049886767524352366\ \(0\)\
\-\ and\\:\\ 0\\.004528528446093546\ \(0\)\
\-\ of\\:\\ 0\\.0029309132276223505\ \(0\)\
\-\ in\\:\\ 0\\.002650297044907264\ \(0\)\
\-\ with\\:\\ 0\\.0022076259639601838\ \(0\)\
\-\ \\.\\:\\ 0\\.0015628726583737352\ \(0\)\
